233 related articles for article (PubMed ID: 12815166)
1. Pharmacological characterization of the human P2Y13 receptor.
Marteau F; Le Poul E; Communi D; Communi D; Labouret C; Savi P; Boeynaems JM; Gonzalez NS
Mol Pharmacol; 2003 Jul; 64(1):104-12. PubMed ID: 12815166
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
von Kügelgen I
Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
[TBL] [Abstract][Full Text] [Related]
3. Involvement of multiple P2Y receptors and signaling pathways in the action of adenine nucleotides diphosphates on human monocyte-derived dendritic cells.
Marteau F; Communi D; Boeynaems JM; Suarez Gonzalez N
J Leukoc Biol; 2004 Oct; 76(4):796-803. PubMed ID: 15240747
[TBL] [Abstract][Full Text] [Related]
4. Identification of a potent inverse agonist at a constitutively active mutant of human P2Y12 receptor.
Ding Z; Kim S; Kunapuli SP
Mol Pharmacol; 2006 Jan; 69(1):338-45. PubMed ID: 16234484
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological and signaling properties of endogenous P2Y1 receptors in cystic fibrosis transmembrane conductance regulator-expressing Chinese hamster ovary cells.
Marcet B; Chappe V; Delmas P; Verrier B
J Pharmacol Exp Ther; 2004 May; 309(2):533-9. PubMed ID: 14742736
[TBL] [Abstract][Full Text] [Related]
6. P2Y-receptors mediating an inhibition of the evoked entry of calcium through N-type calcium channels at neuronal processes.
Kulick MB; von Kügelgen I
J Pharmacol Exp Ther; 2002 Nov; 303(2):520-6. PubMed ID: 12388631
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of the human P2Y11 receptor.
Communi D; Robaye B; Boeynaems JM
Br J Pharmacol; 1999 Nov; 128(6):1199-206. PubMed ID: 10578132
[TBL] [Abstract][Full Text] [Related]
8. Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.
Wirkner K; Schweigel J; Gerevich Z; Franke H; Allgaier C; Barsoumian EL; Draheim H; Illes P
Br J Pharmacol; 2004 Jan; 141(1):141-51. PubMed ID: 14662731
[TBL] [Abstract][Full Text] [Related]
9. Involvement of basic amino acid residues in transmembrane regions 6 and 7 in agonist and antagonist recognition of the human platelet P2Y(12)-receptor.
Hoffmann K; Sixel U; Di Pasquale F; von Kügelgen I
Biochem Pharmacol; 2008 Nov; 76(10):1201-13. PubMed ID: 18809389
[TBL] [Abstract][Full Text] [Related]
10. ADP acting on P2Y13 receptors is a negative feedback pathway for ATP release from human red blood cells.
Wang L; Olivecrona G; Götberg M; Olsson ML; Winzell MS; Erlinge D
Circ Res; 2005 Feb; 96(2):189-96. PubMed ID: 15604418
[TBL] [Abstract][Full Text] [Related]
11. Rat somatostatin receptor type 1 couples to G proteins and inhibition of cyclic AMP accumulation.
Hadcock JR; Strnad J; Eppler CM
Mol Pharmacol; 1994 Mar; 45(3):410-6. PubMed ID: 8145728
[TBL] [Abstract][Full Text] [Related]
12. Agonist action of adenosine triphosphates at the human P2Y1 receptor.
Palmer RK; Boyer JL; Schachter JB; Nicholas RA; Harden TK
Mol Pharmacol; 1998 Dec; 54(6):1118-23. PubMed ID: 9855642
[TBL] [Abstract][Full Text] [Related]
13. Gi-coupled P2Y-ADP receptor mediates GSK-3 phosphorylation and beta-catenin nuclear translocation in granule neurons.
Ortega F; Pérez-Sen R; Miras-Portugal MT
J Neurochem; 2008 Jan; 104(1):62-73. PubMed ID: 17986231
[TBL] [Abstract][Full Text] [Related]
14. Different signal transduction pathways are coupled to the nucleotide receptor and the P2Y receptor in C6 glioma cells.
Lin WW; Chuang DM
J Pharmacol Exp Ther; 1994 Jun; 269(3):926-31. PubMed ID: 8014879
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of a novel cyclic AMP-linked P2 receptor on undifferentiated HL-60 leukemia cells.
Conigrave AD; Lee JY; van der Weyden L; Jiang L; Ward P; Tasevski V; Luttrell BM; Morris MB
Br J Pharmacol; 1998 Aug; 124(7):1580-5. PubMed ID: 9723974
[TBL] [Abstract][Full Text] [Related]
16. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
17. Expression of a cloned P2Y purinergic receptor that couples to phospholipase C.
Filtz TM; Li Q; Boyer JL; Nicholas RA; Harden TK
Mol Pharmacol; 1994 Jul; 46(1):8-14. PubMed ID: 8058061
[TBL] [Abstract][Full Text] [Related]
18. P2Y12 receptor stimulation inhibits beta-adrenergic receptor-induced differentiation by reversing the cyclic AMP-dependent inhibition of protein kinase B.
Van Kolen K; Slegers H
J Neurochem; 2004 Apr; 89(2):442-53. PubMed ID: 15056287
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7).
Olianas MC; Maullu C; Adem A; Mulugeta E; Karlsson E; Onali P
Br J Pharmacol; 2000 Oct; 131(3):447-52. PubMed ID: 11015294
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel human ADP receptor coupled to G(i).
Communi D; Gonzalez NS; Detheux M; Brézillon S; Lannoy V; Parmentier M; Boeynaems JM
J Biol Chem; 2001 Nov; 276(44):41479-85. PubMed ID: 11546776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
